Article Details

Moderna and Merck Announce mRNA-4157/V940, an Investigational ... - PipelineReview.com

Retrieved on: 2022-12-15 16:59:32

Tags for this article:

Click the tags to see associated articles and topics

Moderna and Merck Announce mRNA-4157/V940, an Investigational ... - PipelineReview.com. View article details on HISWAI: https://pipelinereview.com/index.php/2022121582317/Vaccines/Moderna-and-Merck-Announce-mRNA-4157/V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met.html

Excerpt

Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA(R) (pembrolizumab), ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up